News

Beacon AI Centers announced today that Josh Schertzer, former Chief Technology Officer (CTO) of Enterprise Technology at Blackstone, has joined the company as Chief Executive Officer. Schertzer will ...
VIOR INC. ("Vior" or the "Corporation") (FRA: VL51) is pleased to provide an update on exploration activities at its Belleterre Gold Project in Quebec's Belleterre Greenstone Belt. This includes ...
Food solutions company SpartanNash® (the "Company") will announce its financial results before the stock market opens on Thursday, May 29, 2025, for the 16-week first quarter ended April 19, ...
Pending U.S. home sales fell 3.4% year over year during the four weeks ending May 11 to their lowest level on record for this time of year aside from 2020, according to a new report from Redfin ...
Shell plc ? Report on Payments to Governments for the year 2024 Basis for preparation ? Report on Payments to Governments for the year 2024This Report provides a consolidated overview of the payments ...
Officials from the Indianapolis Zoo announce Dr. Lily-Arison René de Roland, renowned scientist and biodiversity ...
Loyola Marymount University will welcome Academy Award-winning filmmaker and multiple Grammy Award-winning Ahmir "Questlove" ...
Rockwell Automation, Inc. , the world's largest company dedicated to industrial automation and digital transformation, today ...
The European industrial equipment market is undergoing significant changes, marked by a surge in online auctions. TBAuctions, Europe's leading digital auction house for used B2B goods, has seen a ...
Duni Group has entered into a strategic partnership with Gothia Cup and Partille World Cup, becoming the official supplier of food and beverage packaging. The two-year collaboration, covering 2025 and ...
The first quarter has been one of the most successful in Metacon's history, both financially and operationally. During the quarter, net sales amounted to SEK 50 million, which corresponds to an ...
TURKU, FI / ACCESS Newswire / May 15, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - Overcoming immune resistance in HR-MDS: Detailed safety and efficacy Phase II data on bexmarilimab to be ...